{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:27:35Z","timestamp":1761056855836},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1006\/mgme.1999.2859","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T19:13:49Z","timestamp":1034018029000},"page":"194-205","source":"Crossref","is-referenced-by-count":21,"title":["Immune Response to Enzyme Replacement Therapy: 4-Sulfatase Epitope Reactivity of Plasma Antibodies from MPS VI Cats"],"prefix":"10.1006","volume":"67","author":[{"given":"Chris T.","family":"Turner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doug A.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mgme.1999.2859_RF1","series-title":"The Metabolic Basis of Inherited Disease","first-page":"2465","article-title":"The Mucopolysaccharidoses","author":"Neufeld","year":"1995"},{"key":"10.1006\/mgme.1999.2859_RF2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1006\/mgme.1999.2859_RF3","series-title":"Organelle Diseases","first-page":"7","article-title":"An introduction to the basic science and biology of the lysosome and storage diseases","author":"Hopwood","year":"1997"},{"key":"10.1006\/mgme.1999.2859_RF4","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI118617","article-title":"Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome","volume":"97","author":"Crawley","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1006\/mgme.1999.2859_RF5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI119208","article-title":"Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI","volume":"99","author":"Crawley","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1006\/mgme.1999.2859_RF6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S8756-3282(97)00175-0","article-title":"Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI","volume":"21","author":"Byers","year":"1997","journal-title":"Bone"},{"key":"10.1006\/mgme.1999.2859_RF7","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1172\/JCI117237","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII","volume":"93","author":"Sands","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1006\/mgme.1999.2859_RF8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem Mol Med"},{"key":"10.1006\/mgme.1999.2859_RF9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.V82.2.408.408","article-title":"Enzyme therapy in Gaucher disease type I: Dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months","volume":"82","author":"Pastores","year":"1993","journal-title":"Blood"},{"key":"10.1006\/mgme.1999.2859_RF10","first-page":"203","article-title":"Enzyme replacement therapy in Mucopolysaccharidosis VI: Evidence for immune responses and altered efficacy of treatment in animal models","volume":"1361","author":"Brooks","year":"1997","journal-title":"Biochem Biophys Acta"},{"key":"10.1006\/mgme.1999.2859_RF11","first-page":"163","article-title":"Immune response to enzyme replacement therapy: Clinical signs of hypersensitivity reactions and altered enzyme distribution in a high titre rat model","volume":"1407","author":"Brooks","year":"1998","journal-title":"Biochem Biophys Acta"},{"key":"10.1006\/mgme.1999.2859_RF12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.V82.5.1402.1402","article-title":"Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase","volume":"82","author":"Richards","year":"1993","journal-title":"Blood"},{"key":"10.1006\/mgme.1999.2859_RF13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V90.1.43","article-title":"Enzyme therapy in Gaucher disease type 1: Effect of neutralizing antibodies to acid \u03b2-glucosidase","volume":"90","author":"Ponce","year":"1997","journal-title":"Blood"},{"key":"10.1006\/mgme.1999.2859_RF14","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.81.13.3998","article-title":"Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid","volume":"81","author":"Geysen","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.1999.2859_RF15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0969-2126(97)00185-8","article-title":"Structure of human lysosomal sulfatase","volume":"5","author":"Bond","year":"1997","journal-title":"Structure"},{"key":"10.1006\/mgme.1999.2859_RF16","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1172\/JCI118558","article-title":"Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A","volume":"97","author":"Gilles","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1006\/mgme.1999.2859_RF17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.100.6.e11","article-title":"Management of neutralizing antibody to ceredase in a patient with type 3 Gaucher disease","volume":"100","author":"Brady","year":"1997","journal-title":"Pediatrics"},{"key":"10.1006\/mgme.1999.2859_RF18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1107\/S0021889891004399","article-title":"MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures","volume":"24","author":"Kraulis","year":"1991","journal-title":"J Appl Cryst"},{"key":"10.1006\/mgme.1999.2859_RF19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0076-6879(97)77028-9","article-title":"RASTER3D photorealistic molecular graphics","volume":"277","author":"Merritt","year":"1997","journal-title":"Methods Enzymol"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719299928597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719299928597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T03:06:17Z","timestamp":1576638377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719299928597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["S1096719299928597"],"URL":"https:\/\/doi.org\/10.1006\/mgme.1999.2859","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}